Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Kingpin68on Mar 08, 2023 10:52am
164 Views
Post# 35325801

RE:TLT is on the verge

RE:TLT is on the vergeI agree Rump. Although the percentages will fluctuate I'm sure, but hopefully keep trending better. If I recall from the last quarterly, 5 of the 6 new 90 days were CR, so that's a great trend.
I also want to point out the potential significance of IR cases, formally Partial Responses. These have a negative cystoscopy, meaning no visible cancer detected (even though some detected in urine). This would surely mean that a patient would be happy about keeping their bladder as opposed to removal. 
Total response at 450 days is 38%, and could easily be close to 50% without the 12 under treated.  So, half of patients save their bladder ? Sounds pretty good.
<< Previous
Bullboard Posts
Next >>